L3Harris Technologies Inc.
L3Harris Reports Strong Q3 2025 Results with Increased Guidance
Summary
L3Harris Technologies, Inc. reported strong financial results for the third quarter of 2025, showing a 7% increase in revenue to $5.7 billion and organic revenue growth of 10%. The company's operating margin expanded to 11.0%, and adjusted segment operating margin reached 15.9%. Diluted earnings per share (EPS) increased 17% to $2.46, and non-GAAP diluted EPS rose 10% to $2.70. L3Harris also raised its full-year 2025 guidance due to strong performance and higher expectations, projecting revenue between $22 billion and $22.25 billion, up from the previous guidance of $21.75 billion to $22 billion.
Profitelligence Alerts
Get alerts for LHX
Be first to know when L3Harris Technologies Inc. files with the SEC.
Filing Categories
Advertisement
About L3Harris Technologies Inc.
L3Harris Technologies Inc. is a leading aerospace and defense technology company offering solutions that impact security, communications, and infrastructure worldwide. Formed through the merger of L3 Technologies and Harris Corporation, L3Harris provides advanced defense systems, communication systems, and electronic systems to government and commercial customers. The company operates across various sectors including space and airborne systems, intelligence and cybersecurity, and aviation systems. It plays a pivotal role in enhancing national security through its innovative products and services, which include tactical communications, geospatial systems, avionics, and cyber security solutions. L3Harris is seen as a crucial player in the global defense industry, contributing to modernizing military capabilities and ensuring strategic technological advancements in aerospace exploration and defense operations. Its operations and technologies are integral to maintaining the functionality and security of critical infrastructure worldwide, with a commitment to meeting the evolving demands of security and defense industries.
Official SEC Documents
Advertisement